Provided by Tiger Trade Technology Pte. Ltd.

Enovis Corporation

25.21
-0.8500-3.26%
Post-market: 25.210.00000.00%16:15 EDT
Volume:625.29K
Turnover:15.89M
Market Cap:1.45B
PE:-1.31
High:26.93
Open:26.28
Low:24.98
Close:26.06
52wk High:34.28
52wk Low:19.14
Shares:57.54M
Float Shares:52.79M
Volume Ratio:0.80
T/O Rate:1.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-19.2212
EPS(LYR):-20.7534
ROE:-54.14%
ROA:1.19%
PB:0.98
PE(LYR):-1.21

Loading ...

Enovis (ENOV) Receives a Buy from Jefferies

TIPRANKS
·
Jul 14

Enovis™ Companion Animal Health Launches CT-RevitL™, the Next-Generation Laser Therapy System for Veterinary Care

GlobeNewswire
·
Jul 13

Enovis (ENOV) Following CMS Reversal, Why The Valuation Story Is Back In Focus

Simply Wall St.
·
Jul 08

Enovis is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Jul 07

Enovis Spotlights Nopain Act Medicare Reimbursement in Becker’s Opioid-sparing Webinar

Reuters
·
Jun 26

BTIG Sticks to Its Buy Rating for Enovis (ENOV)

TIPRANKS
·
Jun 24

Enovis Chief Administrative Officer Oliver Engert acquires 1,000 common shares worth $20,920

Reuters
·
Jun 17

Enovis Chief Administrative Officer Oliver Engert acquires 1,200 common shares for $26,448

Reuters
·
Jun 16

Enovis Chief Administrative Officer Oliver Engert acquires $23,000 in common shares

Reuters
·
Jun 12

CD&R names former Enovis CEO Matthew Trerotola operating advisor

Reuters
·
Jun 11

Enovis Launches Spinamic® Hybrid Scoliosis Brace, Combining Corrective Performance with Improved Wearability for Children and Teens

GlobeNewswire
·
Jun 08

Why Enovis (ENOV) Is Up 9.6% After Beating Q1 Targets And Enhancing Incentive Plan Alignment

Simply Wall St.
·
Jun 08

A Look At Enovis (ENOV) Valuation As Shares Rebound And Long Term Returns Lag

Simply Wall St.
·
Jun 07

Enovis Chief Administrative Officer Oliver Engert buys 1,000 shares worth $22,220

Reuters
·
Jun 04

Enovis Price Target Maintained With a $39.00/Share by BTIG

Dow Jones
·
May 22

Enovis shareholders approve 2020 incentive plan amendment at annual meeting

Reuters
·
May 20

Enovis price target raised to $36 from $35 at Evercore ISI

TIPRANKS
·
May 09

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Capricor Therapeutics (CAPR), Enovis (ENOV) and Progyny (PGNY)

TIPRANKS
·
May 09

Analysts Offer Insights on Healthcare Companies: Opus Genetics (IRD), Enovis (ENOV) and Revelation Biosciences (REVB)

TIPRANKS
·
May 09

Enovis Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
May 08